Value | Category | Cases | |
---|---|---|---|
1 | Oral administration | 9 |
37.5%
|
2 | Intravenous injection | 0 |
0%
|
3 | Topical Application | 0 |
0%
|
4 | Intramuscular injection | 15 |
62.5%
|
5 | Per Vagina | 0 |
0%
|
Sysmiss | 5964 |